Searched for
DOXYCYCLINE
Thyroid, antibiotic drugs face fresh safety warnings after national reviewNew safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential ment...- Pharma firms asked for side-effects of common medicinesIndia's drug regulator has issued new safety warnings for common medicines. Doxycycline, an antibiotic, will now list side effects like anx...
- Indian scientists identify better drug treatment for severe scrub typhusThe study, published in the New England Journal of Medicine (NEJM), shows that treating patients with a combination of intravenous antibiot...
- Alembic Pharma gets USFDA nod for generic drugDoxycycline Hyclate delayed-release tablets are indicated to reduce the development of drug resistant bacteria.
- Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at VadodaraDrug firm Zydus Cadila on Thursday said it has received approval from the US health regulator for manufacturing Doxycycline Injection at it...
- Alembic Pharma gets USFDA nod for its antibiotic capsulesThe approval from USFDA is for the company's abbreviated new drug application (ANDA) in the strengths of 50 mg and 100 mg, Alembic Pharma s...
- Cadila Healthcare rises 2% on USFDA approval to antibiotic drugThis medication is also used for prophylaxis of malaria.
- Zydus gets final nod from USFDA for anti-bacterial drugZydus Cadila is a global pharmaceutical company that develops, manufactures and markets a broad range of healthcare therapies. The group em...
- Lupin launches tablets in US to treat infectionsThe 75 mg and 150 mg tablets were launched after receiving the approval for the from the United States Food and Drug Administration (USFDA)...
- Lupin gets USFDA nod to market anti-infections tabletsThe company has received final approval from the USFDA to market its Doxycycline hyclate tablets USP in the strength of 100 mg.
- Gene therapy via skin may treat diabetes, obesityNew York, Aug 4 (IANS) A new form of gene therapy administered through skin transplants can help improve treatments for Type-2 diabetes and...
- Alembic Pharma gets USFDA go-ahead for anti-bacterial drugThe approved ANDA is therapeutically equivalent to a reference listed drug product Monodox capsules, 75 mg and 100 mg of Aqua Pharmaceutica...
- HSBC says US generic probe concern to weigh on sentiment for pharma cosShares of Sun Pharmaceutical will be closely watched due to its material exposure to doxycycline development amid report that doxycycline-a...
- Sun Pharma gets US subpoena over generic drugs pricingThe subpoena comes amid a wider probe by US regulators into steep increases in the prices of generic medicines in recent years.
- Zydus Cadila gets US FDA nod for Doxycycline capsulesZydus Cadila has received approval from the US FDA to market its generic Doxycycline capsules used for the treatment of bacterial infection...
- Sun Pharma tanks nearly 9% in two sessions on USFDA import alertShares of Sun Pharma continued to remain under pressure for second straight session after the USFDA issued an Import Alert to its plant.
- Sun Pharma slumps over 6% on USFDA import alert; doxycycline prices fallRanjit Kapadia an analyst at Centrum Broking doesn’t see more than 4-5 per cent revenue hit for the company due to import alert.
- Sun Pharma shares gain on strong guidance for doxycyclineSun Pharmaceutical went up 1% after a competitor raised its revenue guidance, citing strong sale of a generic antibiotic also sold by Sun P...
- Lupin gets US nod for Armodafinil tablets, Doxycycline capsulesDrug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsule...
- Ranbaxy gets USFDA nod for Doxycycline TabletsRanbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.
Load More
